Attached files
| file | filename |
|---|---|
| EX-10.4 - EX-10.4 - MYRIAD GENETICS INC | exhibit104-diazperform.htm |
| EX-31.2 - EX-31.2 - MYRIAD GENETICS INC | exhibit312-certificati.htm |
| EX-31.1 - EX-31.1 - MYRIAD GENETICS INC | exhibit311-certificati.htm |
| EX-10.6 - EX-10.6 - MYRIAD GENETICS INC | exhibit106-diazformofs.htm |
| EX-10.5 - EX-10.5 - MYRIAD GENETICS INC | exhibit105-diaztimexba.htm |
| EX-10.3 - EX-10.3 - MYRIAD GENETICS INC | exhibit103-diazrsuagre.htm |
| EX-10.2 - EX-10.2 - MYRIAD GENETICS INC | exhibit102-diazpsuagre.htm |
| EX-10.1 - EX-10.1 - MYRIAD GENETICS INC | exhibit101-diazemploym.htm |
| 10-Q - 10-Q - MYRIAD GENETICS INC | mygn-20200930.htm |
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 9, 2020 | Date: November 9, 2020 | |||||||||||||
| By: | /s/ Paul J. Diaz | By: | /s/ R. Bryan Riggsbee | |||||||||||
| Paul J. Diaz | R. Bryan Riggsbee | |||||||||||||
| President and Chief Executive Officer | Chief Financial Officer | |||||||||||||
| Principal Executive Officer | Principal Financial and Accounting Officer | |||||||||||||